Titan Medical Inc. Registration statement for securities of certain foreign private issuers

Registration statement for securities of certain foreign private issuers

Share Capital - Additional Information (Detail)

Share Capital - Additional Information (Detail)									1 Months Ended			3 Months Ended	12 Months Ended
Share Capital - Additional Information (Detail)	Dec. 23, 2019 USD ($) shares	Mar. 21, 2019 USD ($) $ / shares shares	Aug. 10, 2018 USD ($) $ / shares shares	Jun. 19, 2018 shares	May 10, 2018 USD ($) $ / shares shares	May 10, 2018 USD ($) $ / shares	Apr. 10, 2018 USD ($) shares	Apr. 10, 2018 USD ($) $ / shares	Aug. 29, 2019 USD ($) $ / shares shares	May 29, 2019 USD ($)	May 28, 2019	Mar. 31, 2019 USD ($) shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2019 $ / shares shares	Dec. 31, 2019 $ / shares shares	Dec. 31, 2018 $ / shares shares	Dec. 31, 2018 $ / shares shares	Dec. 31, 2017 $ / shares
Disclosure of classes of share capital [line items]
Number of shares outstanding \| shares				419,888,250											39,907,681	39,907,681	21,675,849	21,675,849
Number of shares outstanding, adjusted \| shares				13,996,275
Reverse stock split ratio				30
Effective date of reverse stock split				Jun. 20, 2018
Offering price per share \| $ / shares		$ 3.40
Cash commission													$ 1,136,146	$ 785,128
Amount allocated to common shares													$ 7,002,043	$ 59,998
Warrant exercised \| shares															1,018,506	1,018,506	6,500	6,500
Number of common shares available for issue under stock option plan \| shares													5,986,152	1,241,803
Stock based compensation													$ 1,651,119	$ 1,505,625
Stock issuance costs													2,090,124	$ 1,297,668
US Dollar [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of options outstanding \| $ / shares																$ 2.65		$ 1.55
Canadian Dollar [Member]
Disclosure of classes of share capital [line items]
Weighted average exercise price of options outstanding \| $ / shares															$ 5.89		$ 18.20		$ 21.30
Warrants expiring between April 10, 2020 and March 21, 2021 [Member]
Disclosure of classes of share capital [line items]
Broker Warrants issued and outstanding \| shares															1,219,276	1,219,276
Warrants expiring between March 16, 2019 and August 10, 2020 [Member]
Disclosure of classes of share capital [line items]
Broker Warrants issued and outstanding \| shares																	786,183	786,183
Before Amendment [Member]
Disclosure of classes of share capital [line items]
Percentage of common shares reserved for issuance											10.00%
After Amendment [Member]
Disclosure of classes of share capital [line items]
Percentage of common shares reserved for issuance										15.00%
Amendment [Member]
Disclosure of classes of share capital [line items]
Stock based compensation													292,184
Incremental stock based compensation										$ 475,622
Over Allotment Option 1 [member]
Disclosure of classes of share capital [line items]
Warrant exercised \| shares												1,018,506
Proceeds from warrant exercised												$ 3,259,219
Amount reclassed from warrant liability to common stock												$ 3,742,824
Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Gross proceeds from offerings													3,000,000
Cash commission													417,113
Aspire Capital Fund LLC [Member] \| Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Shares issued \| shares	973,000								1,777,325						7,784,444	7,784,444
Offering price per share \| $ / shares									$ 1.6879
Gross proceeds from offerings									$ 3,000,000
Capital Issued Commitments	$ 35,000,000								$ 35,000,000
Percentage Of Shares Outstanding									5.30%
Common stock shares issued value	423,440												$ 5,304,531
Stock issuance costs	$ 35,122
Aspire Capital Fund LLC [Member] \| Aspire Agreement [Member] \| Additional Commitment [Member]
Disclosure of classes of share capital [line items]
Shares issued \| shares									639,837
Percentage Of Shares Outstanding									1.90%
Bloom Burton Securities Inc [member]
Disclosure of classes of share capital [line items]
Sale of offering units \| shares		8,455,882	7,679,574				1,126,664
Offering price per share \| (per share)		$ 3.40	$ 2.50			$ 9.00		$ 9.00
Gross proceeds from offerings		$ 28,750,000	$ 19,198,935				$ 8,035,941
Cash commission		2,012,500	1,343,925		$ 76,988		562,516
Net proceeds from offering		$ 25,426,744	$ 17,464,711				7,211,320
Exercise price per share \| (per share)		$ 4.00	$ 3.20			$ 10.50		$ 10.50
Fair value of warrants		$ 15,897,059	$ 6,297,251		658,387	$ 658,387	4,553,700	$ 4,553,700
Amount allocated to common shares		$ 12,852,941	$ 12,901,684		$ 531,469		$ 3,482,241
Warrants expiration period		Mar. 21, 2024	Aug. 10, 2023		Apr. 10, 2023		Apr. 10, 2023
Sale of offering additional units \| shares					168,888
Gross proceeds from additional offerings					$ 1,189,856
Net proceeds from additional offering					$ 1,100,238
Bloom Burton Securities Inc [member] \| Over Allotment Option 1 [member]
Disclosure of classes of share capital [line items]
Fair value of warrants		$ 864,190
Warrants expiration period		Mar. 21, 2021	Aug. 10, 2020		Apr. 10, 2020		Apr. 10, 2020
Broker Warrants to purchase of common stock \| shares		591,911	537,570		10,928		78,867
Common stock price per share \| (per share)		$ 3.40	$ 2.50		$ 9.00			$ 9.00
Northland Securities Inc [Member] \| Aspire Agreement [Member]
Disclosure of classes of share capital [line items]
Cash commission									$ 160,000